In practical terms, a dangerous drug case is about whether a medication was reasonably safe when used as intended and whether the responsible parties provided safety information and manufacturing quality that patients and healthcare providers could rely on. Harm may involve serious allergic reactions, organ damage, bleeding complications, heart rhythm problems, neurological effects, or other injuries that develop after starting a drug or during continued use.
Maryland residents often assume that if a medication is approved or widely prescribed, it must have been “safe.” But product safety and legal responsibility are not the same question. A drug can be harmful for reasons that relate to design, manufacturing quality, or the adequacy of warnings and instructions. When the risk was known, when labeling failed to communicate it clearly, or when quality controls broke down, victims may have grounds to seek compensation.
A key reason these cases are handled carefully is that Maryland courts expect plaintiffs to connect the dots between the medication, the patient’s specific risk factors, and the injuries that followed. That connection typically requires more than personal belief. It usually involves medical records, pharmacy documentation, and expert review that ties scientific evidence to the facts of your situation.


